|
TUFT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.999210E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.175600E-03 |
| Normal-vs-Stage2 |
5.228400E-04 |
| Normal-vs-Stage3 |
2.459700E-03 |
| Normal-vs-Stage4 |
2.680300E-03 |
| Stage1-vs-Stage2 |
4.764800E-03 |
| Stage1-vs-Stage3 |
8.216800E-01 |
| Stage1-vs-Stage4 |
7.471200E-01 |
| Stage2-vs-Stage3 |
4.457700E-03 |
| Stage2-vs-Stage4 |
7.423500E-03 |
| Stage3-vs-Stage4 |
9.140400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.341300E-03 |
| Normal-vs-AfricanAmerican |
9.344500E-03 |
| Normal-vs-Asian |
1.661910E-03 |
| Caucasian-vs-AfricanAmerican |
2.519800E-01 |
| Caucasian-vs-Asian |
4.408400E-01 |
| AfricanAmerican-vs-Asian |
1.203210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.417390E-03 |
| Normal-vs-Female |
2.316500E-03 |
| Male-vs-Female |
2.169000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.864300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.318800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.821750E-03 |
| Normal-vs-Age(81-100Yrs) |
6.523400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.397400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.994600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.770800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.971200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.252800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.931000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.808100E-02 |
| Classical-VS-Follicular |
4.281800E-01 |
| Classical-VS-Other |
6.826000E-01 |
| Classical-VS-Normal |
2.682500E-03 |
| Tall-VS-Follicular |
9.605200E-01 |
| Tall-VS-Other |
8.272800E-01 |
| Tall-VS-Normal |
1.417500E-03 |
| Follicular-VS-Other |
9.087200E-01 |
| Follicular-VS-Normal |
1.823880E-03 |
| Other-VS-Normal |
2.240700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.162230E-03 |
| Normal-vs-N1 |
1.418220E-03 |
| N0-vs-N1 |
8.246800E-01 |
|
|
